Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH).

NCT05495503 is registered in ClinicalTrials.gov with Cryonove Pharma as lead sponsor.

NCT NCT05495503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05495503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH).
Lead sponsor
Cryonove Pharma
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2022
Completion date
December 14, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-inflammatory hyperpigmentation